secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECIGEN, INC. (PGEN)
CIK:        0001356090
Form:       8-K
Filed at:   2022-09-21T23:59:59+00:00
Accession:  0000950103-22-016191
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precigen appoints Rutul R. Shah as COO, effective Oct 1, 2022
-------------------------------------------------------------

- Rutul R. Shah, previously VP Head of Operations, appointed COO; newly created role.
- Base salary increased from $300K to $410K; no other compensation changes disclosed.
- Shah brings 17+ years biopharma experience, 8 focused on gene and cell therapies.
- New COO will oversee strategic portfolio management and operational efficiency.
- Shah will report to President and CEO Helen Sabzevari and join leadership team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356090/000095010322016191/0000950103-22-016191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356090/000095010322016191/dp180846_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-22-016191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer